|
Re: 2023 Outlook per MD&A
|
2
|
Resverlogix Corp.
|
Apr 09, 2023 07:20AM
|
|
Re: Next private placement/licensing agreement
|
2
|
Resverlogix Corp.
|
Feb 06, 2019 05:27PM
|
|
Re: Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension
|
2
|
Resverlogix Corp.
|
Aug 01, 2024 11:34AM
|
|
Re: According to the TMX website there are only 5 million RVX.WT.A oustanding....
|
2
|
Resverlogix Corp.
|
Jun 20, 2019 05:40PM
|
|
Re: Meanwhile back at the outhouse, things are piling up....no tweet about the AGM
|
2
|
Resverlogix Corp.
|
Aug 24, 2019 12:45PM
|
|
Re: CNBC at the JPM Bio Tech Conference
|
2
|
Resverlogix Corp.
|
Jan 08, 2019 02:50PM
|
|
One More Promissory Note-Aug 9/24
|
2
|
Zenith Epigenetics
|
Aug 14, 2024 07:22AM
|
|
Re: Another quarter and not a peep
|
2
|
Resverlogix Corp.
|
Jan 04, 2023 09:43AM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19
|
2
|
Resverlogix Corp.
|
May 24, 2020 09:17AM
|
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
2
|
Resverlogix Corp.
|
Aug 16, 2022 07:16AM
|
|
Re: So they
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 08:56AM
|
|
Re: Warrants conversion!
|
2
|
Resverlogix Corp.
|
Nov 26, 2019 01:04PM
|
|
Re: Additional Exempt Distribution
|
2
|
Zenith Epigenetics
|
Dec 04, 2023 09:51AM
|
|
Re: The runway is clear....
|
2
|
Resverlogix Corp.
|
Dec 08, 2018 11:15AM
|
|
Re: Abstracts 4 of 4: Apabetalone (RVX-208) Reduces ACE2 Expression in Human Cell Culture Systems, Which Could Attenuate SARS-CoV-2 Viral Entry
|
2
|
Resverlogix Corp.
|
Nov 10, 2020 09:34AM
|
|
Re: When to expect the 250th Event
|
2
|
Resverlogix Corp.
|
Feb 27, 2019 02:43PM
|
|
Re: Finally some news
|
2
|
BIOASIS TECHNOLOGIES INC
|
Apr 17, 2022 07:59AM
|
|
Re: RVXCF New 52 week high, $3.59 USD....
|
2
|
Resverlogix Corp.
|
Apr 24, 2019 12:46PM
|
|
Re: RVXCF New 52 week high, $3.59 USD....
|
2
|
Resverlogix Corp.
|
Apr 24, 2019 12:53PM
|
|
Re: Thoughts on ZCC
|
2
|
Zenith Epigenetics
|
Sep 06, 2021 06:01AM
|
